Back to results
US 2004/0082789 A1Published application
Thieno[2,3-c]iosquinolines for use as inhibitors of parp
AssigneesRoberto Pellicciari, Flavio Moroni
InventorsRoberto Pellicciari, Flavio Moroni
Life of this patent
Estimating the term…
Abstract
Heterocyclic derivatives, including derivatives of thieno[2,3-c]isoquinolin-3-one and their use in therapy as inhibitors of poly(ADP-ribose) polymers (PARP), for use in the prevention and treatment of tissue damage due to ischaemia and reperfusion, degenerative diseases, inflammatory diseases, tumour diseases, leukaemia and/or sarcoma.
Claims10
Compounds of formula I, their salts or solvates
- 6
- where
- Y is a hetero atom selected from sulphur (S), nitrogen (N) or oxygen (O),
- R1-R6 are the same or different, and represent hydrogen, hydroxide, an OR7 group, carboxy, COOR7 group, amino group, NHR7 group or halogen, or R5 and R6 taken together form a fused aromatic or non-aromatic 5- or 6-membered ring,
- R7 is a C1-C6 alkyl group, C2-C6 alkenyl group or C3-C7 cycloalkyl group possibly substituted with one or more ioniz, C1-C4 alkoxy, carboxy, C1-C4 alkoxycarbonyl, amino, C1-C6 mono- or dialkylamino groups or halogen.
2 more elements
Dependencies are inferred from the claim text.